Citadel Advisors
VYGR icon

Citadel Advisors’s Voyager Therapeutics VYGR Stock Holding History

Citadel Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.1K Buy
+13,500
New +$53.1K ﹤0.01% 12393
2025
Q2 		– Sell
-37,700
Closed -$127K – 15321
2025
Q1 		$127K Buy
37,700
+14,700
+64% +$68.7K ﹤0.01% 11121
2024
Q4 		$130K Buy
23,000
+14,200
+161% +$91.5K ﹤0.01% 11087
2024
Q3 		$51.5K Sell
8,800
-7,000
-44% -$50.9K ﹤0.01% 11876
2024
Q2 		$125K Sell
15,800
-10,300
-39% -$86.3K ﹤0.01% 10600
2024
Q1 		$243K Buy
26,100
+21,100
+422% +$178K ﹤0.01% 9917
2023
Q4 		$42.2K Sell
5,000
-8,300
-62% -$60.2K ﹤0.01% 11964
2023
Q3 		$103K Buy
13,300
+3,500
+36% +$32K ﹤0.01% 10856
2023
Q2 		$112K Sell
9,800
-2,900
-23% -$30K ﹤0.01% 10752
2023
Q1 		$97.9K Buy
12,700
+11,500
+958% +$91.5K ﹤0.01% 11299
2022
Q4 		$7.32K Buy
+1,200
New +$6.82K ﹤0.01% 13832
2022
Q2 		– Sell
-13,800
Closed -$105K – 14218
2022
Q1 		$105K Sell
13,800
-11,200
-45% -$50K ﹤0.01% 12242
2021
Q4 		$68K Buy
25,000
+2,300
+10% +$7.85K ﹤0.01% 13054
2021
Q3 		$60K Sell
22,700
-110,800
-83% -$360K ﹤0.01% 13267
2021
Q2 		$551K Sell
133,500
-52,200
-28% -$237K ﹤0.01% 9857
2021
Q1 		$875K Buy
185,700
+27,800
+18% +$190K ﹤0.01% 8428
2020
Q4 		$1.13M Buy
+157,900
New +$1.52M ﹤0.01% 6547
2019
Q3 		– Sell
-11,000
Closed -$299K – 9812
2019
Q2 		$299K Buy
+11,000
New +$252K ﹤0.01% 7592

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors's VYGR Position: Q1 2026 in Review

Citadel Advisors reduced its Voyager Therapeutics (VYGR) stake by 34% in Q1 2026, selling an estimated $756K and leaving 364,664 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #6863.

Citadel Advisors first reported a position in VYGR in Q3 2017 and has held it in 32 quarters since. The position peaked at $8.95M in Q3 2020. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Citadel Advisors held 364,664 shares of Voyager Therapeutics worth $1.41M as of Q1 2026.
  • Citadel Advisors sold 191,982 Voyager Therapeutics shares in Q1 2026, an estimated $756K.
  • Voyager Therapeutics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6863 holding.
  • Citadel Advisors first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 32 quarters since.
  • Citadel Advisors's Voyager Therapeutics position peaked at $8.95M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.